VCM
AGIO icon

Versant Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Versant Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.3K Buy
2,001
+1,583
+379% +$48K 0.01% 1097
2026
Q1 		$14.1K Buy
418
+326
+354% +$9.24K ﹤0.01% 1981
2025
Q4 		$2.5K Sell
92
-224
-71% -$7.86K ﹤0.01% 2410
2025
Q3 		$12.7K Hold
316
– – ﹤0.01% 1828
2025
Q2 		$10.5K Buy
+316
New +$9.58K ﹤0.01% 1868
2023
Q3 		– Sell
-64
Closed -$1.81K – 1938
2023
Q2 		$1.81K Buy
+64
New +$1.59K ﹤0.01% 1410

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Versant Capital Management's AGIO Position: Q2 2026 in Review

Versant Capital Management increased its Agios Pharmaceuticals (AGIO) stake by 379% in Q2 2026, buying an estimated $48K and bringing the position to 2,001 shares worth $74.3K. The position accounts for 0.01% of the portfolio, ranked #1097.

Versant Capital Management first reported a position in AGIO in Q2 2023 and has held it in 6 quarters since. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Versant Capital Management held 2,001 shares of Agios Pharmaceuticals worth $74.3K as of Q2 2026.
  • Versant Capital Management bought 1,583 Agios Pharmaceuticals shares in Q2 2026, an estimated $48K.
  • Agios Pharmaceuticals made up 0.01% of Versant Capital Management's portfolio in Q2 2026, its #1097 holding.
  • Versant Capital Management first reported a position in Agios Pharmaceuticals in Q2 2023 and has held it in 6 quarters since.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.